Clinical Trials in Tennessee

Showing 6541-6560 of 20,239 trials

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

This is a first-in-human open-label Phase 1/2a study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of 23ME-00610 given by intravenous infusion in patients with advanced solid malignancies who have progressed on all available standard therapies

Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more

23andMe, Inc.141 participantsStarted Dec 2021

Palo Alto, California, United States • Atlanta, Georgia, United States • Detroit, Michigan, United States +10 more locations

RECRUITINGPhase 129 miles

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

NCT06034275

Dose Escalation - Determine the maximum tolerated dose (MTD), if possible, or minimum optimal biologic dose (OBD), and evaluate the safety and tolerability of VIP943 in subjects with advanced CD123+ hematologic malignancies

Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome

Vincerx Pharma, Inc.36 participantsStarted Sep 2023

Birmingham, Alabama, United States • Cincinnati, Ohio, United States • Nashville, Tennessee, United States +2 more locations

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Find Trials by Condition in Tennessee

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Expanding Rural Health Cancer Control Capacity

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Social Needs App for Oncology Patients Phase II

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Pediatric Adenotonsillectomy Trial for Snoring

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Pediatric Cardiac Output Monitoring Observational Study

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers